Hepatic Encephalopathy Market is expected to reach US$ 511.6 Million by 2027 at CAGR of 5.3% during the forecast period 2017-2023 | Umecrine Cognition AB, Norgine B.V., Abbott Laboratories, and QR Science and Technology Development Co. Ltd.

Global Hepatic Encephalopathy Market

Overview:

Hepatic encephalopathy is a nervous system disorder brought on by severe liver disease. The exact cause of hepatic encephalopathy is unknown. However, it’s usually triggered by a buildup of toxins in the bloodstream. It is a serious but treatable condition. Treatment includes ammonia reduction medication and antibiotics.

𝐆𝐞𝐭 𝐀𝐜𝐜𝐞𝐬𝐬 𝐨𝐟 𝐎𝐮𝐭 𝐋𝐚𝐭𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: @ https://www.coherentmarketinsights.com/insight/request-sample/2596

Drivers:

High prevalence of hepatitis C and hepatic cirrhosis around the world is expected to augment growth of the global hepatic encephalopathy market. For instance, as per the article published in 2018 in the CMAJ Open journal, liver cirrhosis prevalence is expected to increase with the rise in prevalence of hepatitis C and non-alcoholic fatty liver disease in Canada. Around 30% of people in Canada suffer from liver disease.

Moreover, players in the market are adopting various strategies, such as mergers/acquisitions, to strengthen their market position as well as to expand the product portfolio. This in turn is also expected to boost growth of the global hepatic encephalopathy market. For instance, in April 2018, Ferring Pharmaceuticals announced the acquisition of Rebiotix Inc. to explore and understand the human microbiome and to develop new solutions for patients.

Moreover, increasing number of clinical trials and rapid development of new drugs is expected to aid in the growth of the global hepatic encephalopathy market. For instance, in August 2019, Mallinckrodt announced that the company has enrolled the first patient in a phase IIa study on its investigational oral drug MNK-6106 (L-ornithine phenylacetate) to treat hepatic cirrhosis and hepatic encephalopathy.

𝐑𝐞𝐜𝐞𝐢𝐯𝐞 𝐚 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: (𝐈𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐅𝐮𝐥𝐥 𝐓𝐎𝐂, 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐓𝐚𝐛𝐥𝐞𝐬 & 𝐅𝐢𝐠𝐮𝐫𝐞𝐬, 𝐂𝐡𝐚𝐫𝐭) @ https://www.coherentmarketinsights.com/insight/request-pdf/2596

COVID-19 Impact:

The outbreak of COVID-19 (pandemic) has had a negative impact on the growth of the hepatic encephalopathy market. In September 2020, the National center for Biotechnology Information (NCBI) reported that people with severe liver damage need hepatic encephalopathy treatment and treatment may be delayed owing to the outbreak. This is attributed to the unavailability of laxatives, antibiotics, and other medicines and irregular supply and transportation of medicines.

Moreover, in September 2020, the U.S. Food and Drug Administration (FDA) reported that the pandemic has disrupted the supply of drugs due to safety initiatives and temporary shutdowns enforced by several governments to curb the spread of the virus.

Competitive landscape:

Major players active in the global hepatic encephalopathy market are Cosmo Pharmaceuticals N.V., ASKA Pharmaceutical Co., Ltd., Kaleido Biosciences, Lupin Limited, Bausch Health Companies Inc., Kannalife Sciences, Inc., Ferring Pharmaceuticals Inc., Umecrine Cognition AB, Abbott Laboratories, and Mallinckrodt Pharmaceuticals, Norgine, and QR Science and Technology Development Co. Ltd., among others.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/promo/buynow/2596

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Overview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Drug Class
     • Market Snippet, By Route of Administration
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Epidemiology
   • Key Developments
   • Regulatory Scenario
   • Reimbursement Scenario
   • PEST Analysis
4. Global Hepatic Encephalopathy Market – Covid – 19 Impact Analysis
   • During Covid-19 Market Situation
   • Supply Side and Demand Side Analysis
   • Overall Impact on Countries
5. Global Hepatic Encephalopathy Market, By Drug Class, 2016 – 2027 (US$ Million)
   • Introduction
     • Market Share Analysis, 2020 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Antibiotics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Laxatives
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • L-ornithine L-aspartate
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
6. Global Hepatic Encephalopathy Market, By Route of Administration, 2016 – 2027 (US$ Million)
   • Introduction
     • Market Share Analysis, 2020 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Oral
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Intravenous
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Rectal
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
7. Global Hepatic Encephalopathy Market, By Distribution Channel, 2016 – 2027 (US$ Million)
   • Introduction
     • Market Share Analysis, 2020 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)

View Press Release: https://www.coherentmarketinsights.com/press-release/hepatic-encephalopathy-market-to-surpass-us-41513-million-by-2026-1374

About US:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837